Paper · 40468398
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 76
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39037913 | Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity. | Elife | 2024 | https://conductscience.org/library/papers/39037913 | PubMed |
| 2 | 15487979 | Psychological barriers. | Eur J Endocrinol | 2004 | https://conductscience.org/library/papers/15487979 | PubMed |
| 3 | 33463546 | Pharmacological treatment of hyperglycemia in type 2 diabetes. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33463546 | PubMed |
| 4 | 30760847 | Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. | Nat Rev Endocrinol | 2019 | https://conductscience.org/library/papers/30760847 | PubMed |
| 5 | 32872570 | Pathophysiology of Type 2 Diabetes Mellitus. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32872570 | PubMed |
| 6 | 39059739 | Proteomics profiling and association with cardiorenal complications in type 2 diabetes subtypes in Asian population. | Diabetes Res Clin Pract | 2024 | https://conductscience.org/library/papers/39059739 | PubMed |
| 7 | 30672723 | In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion. | Nucleic Acid Ther | 2019 | https://conductscience.org/library/papers/30672723 | PubMed |
| 8 | 31623194 | Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31623194 | PubMed |
| 9 | 34579087 | Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. | Nutrients | 2021 | https://conductscience.org/library/papers/34579087 | PubMed |
| 10 | 37033254 | Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37033254 | PubMed |
| 11 | 33125843 | Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes. | J Med Chem | 2020 | https://conductscience.org/library/papers/33125843 | PubMed |
| 12 | 38095657 | Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial. | Diabetologia | 2024 | https://conductscience.org/library/papers/38095657 | PubMed |
| 13 | 35982037 | Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. | Nat Commun | 2022 | https://conductscience.org/library/papers/35982037 | PubMed |
| 14 | 36342518 | Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes. | Diabetes | 2023 | https://conductscience.org/library/papers/36342518 | PubMed |
| 15 | 31424428 | β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31424428 | PubMed |
| 16 | 37543292 | MicroRNA biomarkers target genes and pathways associated with type 2 diabetes. | Diabetes Res Clin Pract | 2023 | https://conductscience.org/library/papers/37543292 | PubMed |
| 17 | 35484823 | A GLP-1/glucagon (GCG)/CCK2 receptors tri-agonist provides new therapy for obesity and diabetes. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/35484823 | PubMed |
| 18 | 36332637 | Type 2 diabetes. | Lancet | 2022 | https://conductscience.org/library/papers/36332637 | PubMed |
| 19 | 32556613 | Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | Diabetologia | 2020 | https://conductscience.org/library/papers/32556613 | PubMed |
| 20 | 38891870 | MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38891870 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/40468398/references